AtriCurevsJohnson & Johnson

ATRC and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

ATRC

AtriCure, Inc.

$55.45

Value $2.8B

+0.78%
ATRC's page

AtriCure (ATRC) has a market value of $2.8B and Johnson & Johnson (JNJ) $657B. Over the last year, with dividends, ATRC moved +67.4% and JNJ +39.7%. The P/E is 185.6 for ATRC and 40.8 for JNJ. Dividend yield: ATRC none, JNJ 1.94%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ATRC$2.8B

    JNJ$657B

    JNJ is 238 times ATRC

  • Revenue, 12 months

    ATRC$590M

    JNJ$99.3B

    JNJ is 168 times ATRC

  • Net income, 12 months

    ATRC$15M

    JNJ$16.1B

    JNJ is 1,081 times ATRC

  • Operating margin

    ATRC2.9%

    JNJ–

  • ROIC

    ATRC2.8%

    JNJ12.4%

    9.6 points apart

  • P/E

    ATRC185.6

    JNJ40.8

    ATRC is 4.5 times JNJ

  • Dividend yield

    ATRC0.0%

    JNJ1.9%

    1.9 points apart

  • 5-year return

    ATRC-29.2%

    JNJ+92.0%

    121.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ATRC-29.2%

JNJ+92.0%

5010015020020222023202420252026
Returns by period
PeriodATRCWith dividendsJNJWith dividends
1 year since November 17, 2025+67.4%Price +67.4%+39.7%Price +36.6%
3 years since November 17, 2023+33.6%+10.1% a yearPrice +33.6%+98.2%+25.6% a yearPrice +82.1%
5 years since November 17, 2021-29.2%-6.7% a yearPrice -29.2%+92.0%+13.9% a yearPrice +67.0%
10 years since November 21, 2016+183.2%+11.0% a yearPrice +183.2%+209.0%+11.9% a yearPrice +137.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ATRCAtriCureJNJJohnson & Johnson

Valuation

ATRCJNJ
Valuation
Price$55.45$272.70
Market value$2.8B$657B
Enterprise value (EV)$2.7B$685B
P/E185.640.8
P/E, 5-year median–21.9
P/B5.28.1
EV/EBIT156.538.6
Free cash flow yield1.9%3.1%

Results and growth

ATRCJNJ
Results and growth
Revenue, 12 months$590M$99.3B
Net income, 12 months$15M$16.1B
Free cash flow, 12 months$53M$20.6B
Earnings per share, 12 months$0.30$6.59
Revenue growth, year on year14.9%6.1%
Revenue growth a year, past+21.0%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

ATRCJNJ
Margins and returns on capital
Gross margin76.7%67.6%
Operating margin2.9%–
Net margin2.5%16.2%
ROIC2.8%12.4%
ROE3.0%19.7%

Balance sheet

ATRCJNJ
Balance sheet
Cash$187M$17.2B
Total debt$97M$44.7B
Net debt / EBITDA-3.31.1
Interest cover3.0×18.0×

Dividends and buybacks

ATRCJNJ
Dividends and buybacks
Dividend yield–1.9%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield–0.9%
Shareholder yield–2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ATRC or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, AtriCure or Johnson & Johnson?

By market value, Johnson & Johnson ($657B) is about 237.9 times AtriCure ($2.8B), at today's prices.

How did ATRC and JNJ stock do over the last 10 years?

Since November 21, 2016, ATRC's price moved +183.2% and JNJ's +137.1%. With dividends: ATRC +183.2% (+11.0% a year), JNJ +209.0% (+11.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, ATRC or JNJ?

The dividend yield at today's price is none for AtriCure and 1.94% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

What is the P/E of ATRC and JNJ?

At today's price, the P/E is 185.6 for ATRC and 40.8 for JNJ. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, AtriCure or Johnson & Johnson?

Over the last twelve months, the net margin was 2.5% for AtriCure and 16.2% for Johnson & Johnson, and the operating margin 2.9% and –. Revenue was $590M and $99.3B.

Which is the better investment, AtriCure or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.